Dawn Schottlandt

Head of Investor Relations

Geron Corp (GERN)

Head of Investor Relations

Collegium Pharmaceutical, Inc (COLL)

Geron Corp (GERN)

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

Affiliation history

Recorded current and former roles; source labels appear when available.

Geron Corp (GERN)
SEC 8-K

Current
2025-10-20–present
Geron Corp (GERN)
Head of Investor Relations

Source not stated

Current
Collegium Pharmaceutical, Inc (COLL)
Head of Investor Relations

Source not stated

Current

Company network

Recorded roles and earnings-call appearances connecting this person to public companies.

GERN

Current role

Head of Investor Relations

2025-10-20–present

4 calls Latest call 2026-08-05

View earnings calls

Collegium Pharmaceutical, Inc

COLL

Current role

Head of Investor Relations

Recent activity

Earnings-call appearances and filed executive appointments or departures, newest first.

Earnings call Q2 2026 Geron Earnings Conference Call Geron Corp (GERN)
2026-08-05
Earnings call Geron Corp Q1 FY2026 Earnings Call Geron Corp (GERN)
2026-05-06
Earnings call Geron Corp Q4 FY2025 Earnings Call Geron Corp (GERN)
2026-02-25
Earnings call Geron Corp Q3 FY2025 Earnings Call Geron Corp (GERN)
2025-11-05
Executive change Appointed: Senior Vice President, Investor Relations and Corporate Affairs Geron Corp (GERN)
2025-10-20